Home » Shares in Sequenom Up 9.5 Percent on News of Qiagen Dx Alliance

Shares in Sequenom Up 9.5 Percent on News of Qiagen Dx Alliance

Jan 08, 2007
NEW YORK (GenomeWeb News) — Shares in Sequenom were up 9.51 percent, or $.45, at $5.18, in mid-afternoon trading today after the company said it will work with Qiagen to develop a preanalytical product to enrich nucleic acids for prenatal diagnostics.
 
As GenomeWeb News reported this morning, Sequenom will retain commercial rights to any tests the companies develop under the partnership.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.